Vivek Nagaraja

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials

Dinesh Khanna, Vivek Nagaraja, Chi‐Hong Tseng et al. · Arthritis Research & Therapy · 2015 · 126 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Management of Gastrointestinal Involvement in Scleroderma

Vivek Nagaraja, Zsuzsanna H. McMahan, Terri Getzug et al. · Current Treatment Options in Rheumatology · 2015 · 89 citations · Full text

Medicine, Internal Medicine, Pathology +10

Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial

Dinesh Khanna, Cristina M. Padilla, Lam C. Tsoi et al. · JCI Insight · 2022 · 72 citations · Full text

Life Sciences, Dermatology, Immunology +14

Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases

Vivek Nagaraja, Constance A. Mara, Puja Khanna et al. · Quality of Life Research · 2017 · 63 citations · Full text

Medicine, Clinical Sciences, Rheumatology +9

Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort

Amber Young, Victor Moles, Sara Jaafar et al. · Arthritis & Rheumatology · 2021 · 43 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15